8-Allyloxyguanosine
8-Allyloxyguanosine is a purine nucleoside analogue. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc[1].
Product Specifications
CAS Number
[126138-81-6]
UNSPSC
12352005
Target
Nucleoside Antimetabolite/Analog
Type
Oligonucleotides
Related Pathways
Cell Cycle/DNA Damage
Applications
Cancer-programmed cell death
Field of Research
Others
Assay Protocol
https://www.medchemexpress.com/8-allyloxyguanosine.html
Solubility
10 mM in DMSO
Smiles
O[C@H]1[C@@H](O)[C@H](N2C(N=C(N)NC3=O)=C3N=C2OCC=C)O[C@@H]1CO
Molecular Formula
C13H17N5O6
Molecular Weight
339.30
References & Citations
[1]Robak T, Robak P. Purine nucleoside analogs in the treatment of rarer chronic lymphoid leukemias. Curr Pharm Des. 2012;18 (23) :3373-88.
Shipping Conditions
Room temperature
Scientific Category
Oligonucleotides
Clinical Information
No Development Reported
Explore Other Products
Browse additional items from our catalog
HRH2 (NM_001131055) Human Tagged ORF Clone Lentiviral Particle
TRA (T Cell Receptor alpha Locus, FLJ22602, MGC117436, MGC22624, MGC23964, MGC71411, T-cell Receptor alpha Chain V Region CTL-L17, TCRA, TCRD, TRA) (Biotin)
TRA (T Cell Receptor alpha Locus, FLJ22602, MGC117436, MGC22624, MGC23964, MGC71411, T-cell Receptor alpha Chain V Region CTL-L17, TCRA, TCRD, TRA) (Biotin)
